Literature DB >> 27883213

Oxidative Stress and Amyloid Toxicity: Insights From Yeast.

Mauro B França1, Karina C Lima1, Elis C A Eleutherio1.   

Abstract

Alzheimer's disease is the most common neurodegenerative disorder. One of the factors that promotes neurodegeneration is the accumulation of senile plaques formed by Aβ peptide. In this paper, it was analyzed that if oxidative stress is cause or consequence of amyloid cascade and the role of antioxidant defense system in this process, using S. cerevisiae (with a multicopy plasmid containing the Aβ1-42 sequence) as experimental model. Cells grown on glycerol were more tolerant than when grown on glucose, strengthening the role of the antioxidant defense system against Aβ accumulation. Antioxidant defense deficiency did not change the pattern of amyloid aggregation. On the other hand, the presence of Aβ increased the level of intracellular oxidation and induced the activity of catalase, superoxide dismutase, and aconitase. Peroxissomal catalase deficient cells (Δcta1), were more sensitive to Aβ toxicity than the wild type strain, while mitochondrial superoxide dismutase (Sod2) deficient cells displayed the highest frequency of petites. Besides, Aβ alters the oxygen consumption and the activity of complex III and IV. Taken together, our results point out that the Aβ toxicity mechanism involves an oxidative stress induction by increasing ROS production into the mitochondria, where Cta1 and Sod2 play a crucial role in the regulation of the redox balance. J. Cell. Biochem. 118: 1442-1452, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALZHEIMER; BETA-AMYLOID; CATALASE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; YEAST

Mesh:

Substances:

Year:  2017        PMID: 27883213     DOI: 10.1002/jcb.25803

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice.

Authors:  Karin Sandoval; David Umbaugh; Austin House; Albert Crider; Ken Witt
Journal:  Neurochem Res       Date:  2019-10-19       Impact factor: 3.996

2.  Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia.

Authors:  Ashok Silwal; Austin House; Karin Sandoval; Shaluah Vijeth; David Umbaugh; Albert Crider; Shirin Mobayen; William Neumann; Ken A Witt
Journal:  Neurochem Res       Date:  2021-11-30       Impact factor: 3.996

3.  Nicotinamide Reduces Amyloid Precursor Protein and Presenilin 1 in Brain Tissues of Amyloid Beta-Tail Vein Injected Mice.

Authors:  Eun Jin Kim; Soo Jin Yang
Journal:  Clin Nutr Res       Date:  2017-04-30

Review 4.  Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.

Authors:  Christian Griñán-Ferré; Rubén Corpas; Dolors Puigoriol-Illamola; Verónica Palomera-Ávalos; Coral Sanfeliu; Mercè Pallàs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities.

Authors:  Muhammad Ovais; Nashmia Zia; Irshad Ahmad; Ali Talha Khalil; Abida Raza; Muhammad Ayaz; Abdul Sadiq; Farhat Ullah; Zabta Khan Shinwari
Journal:  Front Aging Neurosci       Date:  2018-10-23       Impact factor: 5.750

6.  S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer's Disease Features Progression in TgCRND8 Mice.

Authors:  Rosaria A Cavallaro; Vincenzina Nicolia; Maria Teresa Fiorenza; Sigfrido Scarpa; Andrea Fuso
Journal:  Antioxidants (Basel)       Date:  2017-09-30

7.  Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.

Authors:  Akhil Kumar; Ashish Tiwari; Ashok Sharma
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.